StapleBio Co.
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $3M
Investors
- 5
About StapleBio Co.
, Ltd. operates as a pharmaceutical company that develops drugs. The company was founded by its CEO, Kiyoshi Tanigawa, and CSO, Yosuke Katsuta. In April 2024, StapleBio Inc. StapleBio develops pharmaceuticals with the help of its next-generation nucleic acid medicine technology. The firm’s product line includes Staple nucleic acids, a next-generation nucleic acid drug technology that can target specific RNA molecules linked to diseases and alter their structure, which can regulate protein production, potentially offering a treatment for various diseases.
Who invested in StapleBio Co.
5 investors across 1 round
See all investors in StapleBio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 1, 2024
Amount
$3M
Investors
Questions about StapleBio Co.
Who invested in StapleBio Co.?
StapleBio Co. has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has StapleBio Co. raised?
StapleBio Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did StapleBio Co. last raise money?
StapleBio Co.'s most recent round on record is a Series A, in Apr 2024.
What does StapleBio Co. do?
StapleBio Co. is a pharmaceuticals company.
Where is StapleBio Co. headquartered?
StapleBio Co. is headquartered in Kumamoto, Japan.
Which VCs invest in companies like StapleBio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at StapleBio Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like StapleBio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.